Maxacalcitol

Maxacalcitol
Product Description

produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis

Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.

  • CN
  • 2019
    On CPHI since
Specifications
  • CAS Registry Number
    103909-75-7
  • Supplied from
    China

Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.

  • CN
  • 2019
    On CPHI since

More Products from Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd. (2)

  • Dexlansoprazole Sodium

    Product Dexlansoprazole Sodium

    produced under GMP conditions, indicated for Gastric ulcer, duodenal ulcer and reflux esophagitis
  • Calcifediol

    Product Calcifediol

    in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.

Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd. resources (2)

  • News Heron Pharma attended CPHI China 2019

    Many thanks to the customers visiting us on  at booth E2G39 on CPHI China 2019. Let's meet again on CPHI China 2020 at W2B25 in Shanghai, Jun. 22-24th 2020.
  • Video Heron Pharma Interview

    Heron Pharmaceutical Science & Technology Co., Ltd. was founded in 2013 and grew fast in the past 6 years. Chuangye Jiangsu 8090+ interviewed Heron Pharma on July 4th, 2019 since this company is one successful case of New Born Company in Nanjing City. This video could help more people to understand Heron Pharma and know more interest details how we work.